A Companion App to Support Rheumatology Patients Treated with Certolizumab Pegol: Results From a Usability Study.

Barbara Domańska Stijn Vansant Irina Mountian

Published in: JMIR formative research (2020)

In simulated testing, patients were able to successfully use the companion app without formal training. This study suggests the companion app is easy to use and could help patients prescribed CZP better manage their treatment and disease.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
social media
health information
juvenile idiopathic arthritis
patient reported
virtual reality